Navigation Links
New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput
Date:11/1/2007

CAMBRIDGE, England, November 1 /PRNewswire-FirstCall/ -- Capsugel will unveil the successor to its unique Xcelodose system for micro-dosing of drug powders into capsules and vials at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in San Diego (November 11th -15th, 2007).

The new Xcelodose S system will feature a 50% increase in throughput rate for filled capsules. Additional improvements include an integral High Throughput Unit and expanded software functionality.

These enhancements will be available in both the 120 and 600 models, which will replace the existing Xcelodose products. The Xcelodose system, launched in 2002, revolutionized the preparation of drug materials for early stage clinical trials and formulation development. For the first time, pharmaceutical companies could fill pure Active Pharmaceutical Ingredient (API) directly into capsules or other small dose containers, with a level of accuracy and precision previously unattainable.

By automatically dispensing drug substance alone into capsules, pharmaceutical companies can benefit from a reduction in development time by as much as six months. Eliminating the need for formulation for early stage trials enables companies to more quickly reach the crucial "Go/No Go" point for continuing development following Phase I clinical studies. In short, the Xcelodose system has made achieving the goal of "Faster Time to First in Man" a reality.

David Edwards, Director of Pharmaceutical Technology for Capsugel, said the impetus behind the new generation of Xcelodose machines was increased throughput. "Since we originally launched Xcelodose, we have found that batch sizes have increased tenfold; from thousands of capsules per batch, to tens of thousands or more per batch. It became clear that the number one customer requirement was for increased throughput, followed closely by reliability over longer runs."

Keith Hutchison, Capsugel's Vice-President of R&D, re-affirmed the company's commitment to innovation. "With more than 50 Xcelodose systems installed at pharmaceutical, biotech and CRO companies worldwide, capsule micro-filling has become an established technology for early stage clinical trials. Our goal with the Xcelodose S is to substantially advance our strategy of providing innovative solutions to our customers."

The new Xcelodose S system will be featured at Capsugel Booth #691 at the AAPS Annual Meeting.

Note to Editors:

Capsugel, the world's leading provider of dosage form solutions to the pharmaceutical and related healthcare industries, is a division of Pfizer Inc. Offering a diverse array of products and services, Capsugel is at the forefront of drug delivery innovation. Recent product launches include the CFS 1200 Liquid Filling and Sealing Machine and the Xcelodose S Precision Powder Micro-filling System. Both utilize advanced technology that can better enable R&D scientists to accelerate the pace of drug development.


'/>"/>
SOURCE Capsugel
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Indian Doctor granted US patent on organ regeneration
2. New Laser Techniques cure degeneration of the eye
3. Proper Diet Can Counter Macular Degeneration
4. Fast screening for macular degeneration
5. Gene treatment for macular degeneration
6. Laser may stop macular degeneration
7. Macular Degeneration treatment with Laser
8. Age-Related Macular Degeneration - Risk Factors
9. Regeneration of muscle
10. Effective Treatment Option For Macular Degeneration
11. Third generation Small pox vaccine from Cell-culture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Women's ... , Roberta Jordan is a Certified Nurse Midwife who was born and raised ... then went on to complete her masters degree from the University of Mexico. ...
(Date:5/24/2016)... ... 24, 2016 , ... Educational opportunities, and therefore life chances, ... communities providing richer opportunities. Recognizing the key role of housing in this system, ... school choice policies; (c) school desegregation policies; (d) wealth-focused policies; and (e) housing-focused ...
(Date:5/24/2016)... ... 24, 2016 , ... Regenerative Medicine is being transformed by ongoing research and ... protocols and patient results as have been achieved with Okyanos Cell Therapy ... of care for patients worldwide. , As the Medical Advisory Chairman at Okyanos, Eric ...
(Date:5/24/2016)... ... 2016 , ... Backed by decades of experience, Metroloji Okulu ... the best suited solution to meet regulatory requirements. Their professional staff also performs ... Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and pharmaceutical ...
(Date:5/24/2016)... ... May 24, 2016 , ... American Gene Technologies ... to its board of directors. Otterstatter is co-founder, president and CEO of ... technological innovations that lead to broad-based healthcare solutions. , “Jon knows how to ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
(Date:5/24/2016)... LAWRENCE, Mass. , May 24, 2016  NxStage ... medical technology company focused on advancing renal care, today ... Officer, plans to participate in the following schedule of ... will be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, ...
(Date:5/24/2016)... , May 24, 2016 ... de doble terapia del mundo, introduce catéteres para ... OrbusNeich, una compañía global especializada en ... vidas, ha expandido su cartera incluyendo productos para ... JADE™ y Scoreflex™ PTA son los dispositivos de ...
Breaking Medicine Technology: